Cash flow Shanghai Sanyou Medical Co., Ltd

Equities

688085

CNE1000040J7

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 20/04/2026			5-day change	1st Jan Change
17.50 ^CNY	+0.29%		-2.78%	-2.89%

03-16	Zhuiyuan Medical Technology Co., Ltd. announced that it has received CNY 25 million in funding from Shanghai Sanyou Medical Co., Ltd, Shanghai Kinetic Medical Co., Ltd	CI
03-05	Shanghai Sanyou Medical's Implanet Secures FDA Clearance for 3D-Printed Spinal System	MT

8c169023f77069eb206df8d72c0f.G55tBEMdyjPKdmIfoRqvAaE3UjcCBUHrFCdrKzSKVzc.desCcxdQhFCPHQRA_kOWZ-RjJmhSMBCEU0UjZmXND25v9ztddG-Gdp5bKw

Published financial data: SHANGHAI SANYOU MEDICAL CO., LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	390M	593M	648M	457M	452M
Other Revenues, Total	84.51K	413K	1.35M	3.48M	1.9M
Total Revenues	390M	593M	649M	460M	454M
Cost of Goods Sold, Total	40.27M	63.61M	71.39M	104M	146M
Gross Profit	350M	530M	578M	357M	308M
Selling General & Admin Expenses, Total	205M	323M	334M	193M	212M
Provision for Bad Debts	2.49M	2.87M	2.79M	-8.76M	1.05M
R&D Expenses	33.92M	56.55M	60.38M	65.22M	84.29M
Other Operating Expenses	4M	6.49M	7.68M	5.07M	4.46M
Other Operating Expenses, Total	246M	389M	404M	255M	302M
Operating Income	104M	141M	173M	102M	6.14M
Interest Expense, Total	-	-161K	-203K	-268K	-1.17M
Interest And Investment Income	23.66M	34.3M	14.53M	16.25M	13.6M
Net Interest Expenses	23.66M	34.14M	14.33M	15.99M	12.42M
Currency Exchange Gains (Loss)	-329K	-168K	97.08K	322K	-740K
Other Non Operating Income (Expenses)	1.67M	186K	-200K	-307K	-1.43M
EBT, Excl. Unusual Items	129M	175M	188M	118M	16.39M
Impairment of Goodwill	-	-	-	-	-72K
Gain (Loss) On Sale Of Investments	-	27.33M	36.32M	-6.89M	4.16M
Gain (Loss) On Sale Of Assets	-	-189K	-61.9K	-45.87K	6.42M
Asset Writedown	-	-	-	-	-10.13M
Other Unusual Items	7.61M	15.33M	15.78M	24.22M	5.13M
EBT, Incl. Unusual Items	137M	217M	240M	135M	21.9M
Income Tax Expense	18.39M	22.18M	35.99M	21.23M	9.79M
Earnings From Continuing Operations	119M	195M	204M	114M	12.11M
Net Income to Company	119M	195M	204M	114M	12.11M
Minority Interest	-	-8.78M	-12.74M	-18.06M	-644K
Net Income - (IS)	119M	186M	191M	95.58M	11.47M
Net Income to Common Incl Extra Items	119M	186M	191M	95.58M	11.47M
Net Income to Common Excl. Extra Items	119M	186M	191M	95.58M	11.47M
Per Share Items
Net EPS - Basic	0.43	0.63	0.64	0.32	0.04
Basic EPS - Continuing Operations	0.43	0.63	0.64	0.32	0.04
Basic Weighted Average Shares Outstanding	273M	297M	300M	302M	275M
Net EPS - Diluted	0.43	0.63	0.64	0.32	0.04
Diluted EPS - Continuing Operations	0.43	0.63	0.64	0.32	0.04
Diluted Weighted Average Shares Outstanding	273M	297M	300M	302M	275M
Normalized Basic EPS	0.3	0.34	0.35	0.18	0.03
Normalized Diluted EPS	0.3	0.34	0.35	0.18	0.03
Dividend Per Share	0.12	0.13	0.06	0.06	0
Payout Ratio	-	19.24	19.58	20.09	197.5
Supplemental Items
EBITDA	114M	154M	187M	126M	36.41M
EBITA	105M	142M	175M	105M	14.77M
EBIT	104M	141M	173M	102M	6.14M
EBITDAR	114M	154M	188M	127M	37.31M
Total Revenues (As Reported)	390M	593M	649M	460M	454M
Effective Tax Rate - (Ratio)	13.43	10.21	15.02	15.74	44.7
Total Current Taxes	19.8M	26.35M	33.14M	6.94M	5.75M
Total Deferred Taxes	-1.41M	-4.17M	2.85M	14.29M	4.04M
Normalized Net Income	80.83M	101M	104M	55.43M	9.6M
Interest on Long-Term Debt	-	241K	203K	268K	-
Non-Cash Pension Expense	-	-	15K	38.5K	-
Supplemental Operating Expense Items
Marketing Expenses	6.7M	13.55M	8.76M	6.66M	10.59M
Selling and Marketing Expenses	186M	295M	297M	161M	145M
General and Administrative Expenses	19.5M	28.36M	36.68M	31.98M	67.16M
Research And Development Expense From Footnotes	33.92M	56.55M	60.38M	65.22M	84.29M
Net Rental Expense, Total	452K	595K	595K	566K	899K
Imputed Operating Lease Interest Expense	-	-	185K	234K	326K
Imputed Operating Lease Depreciation	-	-	410K	332K	573K
Stock-Based Comp., R&D Exp. (Total)	-	990K	766K	-	7.33M
Stock-Based Comp., S&M Exp. (Total)	-	1.12M	-	-	241K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	196K
Total Stock-Based Compensation	-	2.11M	766K	-	7.76M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	262M	382M	340M	654M	403M
Short Term Investments	-	-	-	-	235M
Trading Asset Securities, Total	881M	377M	193M	19.63M	50.23M
Total Cash And Short Term Investments	1.14B	759M	534M	674M	688M
Accounts Receivable, Total	197M	253M	275M	61.53M	73.14M
Other Receivables	2.91M	2.4M	2.75M	940K	3.98M
Total Receivables	200M	255M	278M	62.46M	77.12M
Inventory	93.19M	121M	155M	177M	246M
Other Current Assets, Total	4.55M	14.91M	27.68M	33.19M	22.25M
Total Current Assets	1.44B	1.15B	994M	946M	1.03B
Gross Property Plant And Equipment	196M	321M	419M	441M	509M
Accumulated Depreciation	-39.74M	-64.5M	-73.21M	-96.75M	-163M
Net Property Plant And Equipment	156M	256M	345M	344M	347M
Long-term Investments	10M	182M	425M	490M	426M
Goodwill	-	315M	315M	315M	346M
Other Intangibles, Total	23.79M	32.81M	40.98M	85.59M	88.71M
Deferred Tax Assets Long-Term	13.53M	30.27M	33.65M	22.69M	3.8M
Deferred Charges Long-Term	20.22M	22.74M	26.17M	45.58M	32.49M
Other Long-Term Assets, Total	6.31M	6.87M	10.26M	11.88M	29.19M
Total Assets	1.67B	2B	2.19B	2.26B	2.31B
Liabilities
Accounts Payable, Total	65.81M	20.25M	28.06M	26.69M	58.44M
Accrued Expenses, Total	25.54M	123M	132M	77.67M	56.08M
Short-term Borrowings	-	-	-	-	15.25M
Current Portion of Long-Term Debt	-	-	-	-	8.5M
Current Portion of Leases	-	2.59M	3.08M	4.15M	6.76M
Current Income Taxes Payable	5.35M	13.67M	12.81M	1.09M	1.46M
Unearned Revenue Current, Total	624K	10.7M	9.73M	4.74M	6.23M
Other Current Liabilities	26.35M	65.13M	59.25M	80.1M	72.11M
Total Current Liabilities	124M	235M	245M	194M	225M
Long-Term Debt	-	-	-	-	8.38M
Long-Term Leases	-	2.49M	2.3M	834K	8M
Unearned Revenue Non Current	4.74M	6.83M	7.85M	6.69M	7.12M
Pension & Other Post Retirement Benefits	-	-	-	-	1.64M
Deferred Tax Liability Non Current	-	4.1M	10.6M	16.11M	6.9M
Other Non Current Liabilities	7.83M	12.56M	12.56M	719K	1.04M
Total Liabilities	136M	261M	278M	219M	258M
Common Stock, Total	205M	205M	226M	248M	248M
Additional Paid In Capital	1.05B	1.05B	1.03B	1.01B	1.02B
Retained Earnings	275M	426M	579M	656M	648M
Comprehensive Income and Other	-	-2.2K	40.68K	104K	-521K
Total Common Equity	1.53B	1.69B	1.84B	1.92B	1.91B
Minority Interest	-	50.42M	73.27M	127M	137M
Total Equity	1.53B	1.74B	1.91B	2.04B	2.05B
Total Liabilities And Equity	1.67B	2B	2.19B	2.26B	2.31B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	298M	298M	298M	298M	333M
ECS Total Common Shares Outstanding	298M	298M	298M	298M	298M
Book Value / Share	5.15	5.65	6.17	6.43	6.41
Tangible Book Value	1.51B	1.34B	1.48B	1.52B	1.48B
Tangible Book Value Per Share	5.07	4.49	4.98	5.08	4.95
Total Debt	0	5.07M	5.39M	4.99M	46.9M
Net Debt	-1.14B	-754M	-528M	-669M	-641M
Debt Equivalent Oper. Leases	3.61M	4.76M	4.76M	4.53M	7.19M
Minority Interest, Total (Incl. Fin. Div)	-	50.42M	73.27M	127M	137M
Equity Method Investments, Total	-	10.13M	32.02M	25.04M	13.3M
Account Code - Inventory Valuation	6	-	6	6	6
Inventories - Raw Materials, Total	17.75M	26.94M	26.59M	33.9M	41.82M
Inventories - Work In Process, Total	18.54M	22.12M	35.48M	49.67M	53.26M
Inventories - Finished Goods, Total	73.17M	93.92M	120M	22.49M	34.32M
Inventories - Others	3.3M	2.4M	371K	105M	163M
Buildings, Total	106M	106M	246M	258M	257M
Machinery, Total	87.69M	102M	137M	142M	185M
Full Time Employees	333	442	434	466	514
Accumulated Allowance for Doubtful Accounts (Supple)	11.57M	14.43M	17.22M	8.47M	10.36M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	119M	186M	191M	95.58M	11.47M
Depreciation & Amortization - CF	8.87M	13.72M	15.82M	25.37M	28.28M
Amortization of Goodwill and Intangible Assets - (CF)	452K	1.77M	2.04M	3.26M	8.63M
Depreciation & Amortization, Total	9.32M	15.49M	17.86M	28.63M	36.91M
Amortization of Deferred Charges, Total - (CF)	10.05M	12.65M	16.36M	25.75M	24.51M
(Gain) Loss From Sale Of Asset	-	-37.56K	61.9K	45.87K	-6.43M
(Gain) Loss on Sale of Investments - (CF)	-20.43M	-26.44M	-46.76M	6.89M	-5.68M
Asset Writedown & Restructuring Costs	4.63M	-24.5M	2.9M	-	10.22M
Provision for Credit Losses	779K	7.23M	12.78M	-	-
Provision and Write-off of Bad Debts	-	-	-	-8.76M	1.05M
Other Operating Activities, Total	329K	9.11M	12.83M	29.58M	18.56M
Change In Accounts Receivable	-32.14M	-70.1M	-39.32M	215M	2.06M
Change In Inventories	-40.4M	-40.6M	-55.03M	-73.57M	-68.15M
Change In Accounts Payable	25.32M	75.88M	39.84M	-65.73M	-25.46M
Change In Deferred Taxes	-1.41M	-4.17M	2.85M	14.56M	4.04M
Change in Other Net Operating Assets	2.91M	4.04M	774K	-232K	7.87M
Cash from Operations	77.52M	145M	156M	267M	10.96M
Capital Expenditure	-30.45M	-91.66M	-138M	-25.94M	-37.44M
Sale of Property, Plant, and Equipment	206	371K	-	153K	5.42M
Cash Acquisitions	-	-268M	-970K	-30.38M	-
Investment in Marketable and Equity Securities, Total	-820M	356M	-25.86M	124M	-204M
Other Investing Activities, Total	20.42M	16.14M	8.88M	1.08M	2.76M
Cash from Investing	-830M	12.36M	-156M	68.8M	-234M
Long-Term Debt Issued, Total	-	-	-	-	45.14M
Total Debt Issued	-	-	-	-	45.14M
Long-Term Debt Repaid, Total	-	-1.46M	-4.52M	-3.55M	-51.94M
Total Debt Repaid	-	-1.46M	-4.52M	-3.55M	-51.94M
Issuance of Common Stock	995M	-	-	-	-
Common Dividends Paid	-	-35.86M	-37.37M	-19.2M	-22.65M
Common & Preferred Stock Dividends Paid	-	-35.86M	-37.37M	-19.2M	-22.65M
Other Financing Activities, Total	-17.06M	-	-	-	1.28M
Cash from Financing	978M	-37.32M	-41.9M	-22.75M	-28.17M
Foreign Exchange Rate Adjustments	-329K	-104K	192K	444K	-469K
Net Change in Cash	225M	120M	-41.88M	314M	-251M
Supplemental Items
Cash Income Tax Paid (Refund)	45.84M	69.84M	119M	71.76M	19.75M
Levered Free Cash Flow	78.6M	41.23M	-54.62M	229M	-34.28M
Unlevered Free Cash Flow	78.6M	41.33M	-54.49M	229M	-33.55M
Change In Net Working Capital	-24.47M	-14.81M	59.58M	-137M	69.14M
Net Debt Issued / Repaid	-	-1.46M	-4.52M	-3.55M	-6.8M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.87	4.8	5.17	2.85	0.17
Return on Total Capital	6.61	5.37	5.92	3.2	0.19
Return On Equity %	12.02	11.93	11.16	5.75	0.59
Return on Common Equity	12.02	11.57	10.82	5.09	0.6
Margin Analysis
Gross Profit Margin %	89.69	89.28	89	77.45	67.82
SG&A Margin	52.61	54.46	51.4	42.02	46.67
EBITDA Margin %	29.11	25.94	28.88	27.37	8.03
EBITA Margin %	26.84	24.01	27.01	22.77	3.26
EBIT Margin %	26.72	23.71	26.69	22.06	1.35
Income From Continuing Operations Margin %	30.37	32.89	31.36	24.68	2.67
Net Income Margin %	30.37	31.41	29.39	20.76	2.53
Net Avail. For Common Margin %	30.37	31.41	29.39	20.76	2.53
Normalized Net Income Margin	20.7	16.94	16.09	12.04	2.12
Levered Free Cash Flow Margin	20.13	6.95	-8.41	49.67	-7.56
Unlevered Free Cash Flow Margin	20.13	6.97	-8.39	49.7	-7.4
Asset Turnover
Asset Turnover	0.35	0.32	0.31	0.21	0.2
Fixed Assets Turnover	2.63	2.88	2.16	1.34	1.31
Receivables Turnover (Average Receivables)	2.13	2.64	2.45	2.71	6.71
Inventory Turnover (Average Inventory)	0.5	0.59	0.52	0.63	0.69
Short Term Liquidity
Current Ratio	11.65	4.9	4.06	4.87	4.6
Quick Ratio	10.86	4.32	3.31	3.79	3.4
Operating Cash Flow to Current Liabilities	0.63	0.62	0.64	1.38	0.05
Days Sales Outstanding (Average Receivables)	171.61	138.52	148.82	134.56	54.56
Days Outstanding Inventory (Average Inventory)	733.42	615.94	707.04	583.23	530.1
Average Days Payable Outstanding	374.14	170.92	83.97	79.68	72.32
Cash Conversion Cycle (Average Days)	530.89	583.54	771.89	638.11	512.33
Long Term Solvency
Total Debt/Equity	-	0.29	0.28	0.24	2.29
Total Debt / Total Capital	-	0.29	0.28	0.24	2.24
LT Debt/Equity	-	0.14	0.12	0.04	0.8
Long-Term Debt / Total Capital	-	0.14	0.12	0.04	0.78
Total Liabilities / Total Assets	8.16	13.06	12.7	9.67	11.18
EBIT / Interest Expense	-	875.37	854.25	378.9	5.23
EBITDA / Interest Expense	-	971.75	942.31	485.69	36.66
(EBITDA - Capex) / Interest Expense	-	401.51	261.02	388.94	4.78
Total Debt / EBITDA	-	0.03	0.03	0.04	1.09
Net Debt / EBITDA	-10.06	-4.83	-2.76	-5.14	-14.89
Total Debt / (EBITDA - Capex)	-	0.08	0.1	0.05	8.35
Net Debt / (EBITDA - Capex)	-13.74	-11.68	-9.98	-6.42	-114.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.19	51.97	9.4	-29.08	-1.48
Gross Profit, 1 Yr. Growth %	9.82	51.29	9.06	-38.28	-13.72
EBITDA, 1 Yr. Growth %	4.12	34.56	21.83	-33.21	-71.42
EBITA, 1 Yr. Growth %	1.17	35.04	23.05	-40.58	-86.1
EBIT, 1 Yr. Growth %	1.6	34.87	23.15	-41.38	-93.95
Earnings From Cont. Operations, 1 Yr. Growth %	20.9	64.6	4.31	-44.17	-89.34
Net Income, 1 Yr. Growth %	21.2	57.2	2.39	-49.91	-88
Normalized Net Income, 1 Yr. Growth %	23.26	24.34	3.92	-46.93	-82.68
Diluted EPS Before Extra, 1 Yr. Growth %	-1.57	44.43	1.21	-50.65	-86.83
Accounts Receivable, 1 Yr. Growth %	16.75	28.26	8.89	-77.66	18.88
Inventory, 1 Yr. Growth %	36.68	30.35	27.67	13.91	39.31
Net Property, Plant and Equip., 1 Yr. Growth %	10.84	64.41	34.77	-0.38	0.72
Total Assets, 1 Yr. Growth %	202.95	19.54	9.72	3.2	2
Tangible Book Value, 1 Yr. Growth %	264.07	-11.44	10.89	2.14	-2.51
Common Equity, 1 Yr. Growth %	250.48	9.87	9.13	4.16	-0.23
Cash From Operations, 1 Yr. Growth %	25.6	86.94	7.63	71.46	-95.9
Capital Expenditures, 1 Yr. Growth %	-61.79	201.01	50.77	-81.23	44.33
Levered Free Cash Flow, 1 Yr. Growth %	-187.23	-47.54	-232.47	-518.64	-114.99
Unlevered Free Cash Flow, 1 Yr. Growth %	-187.23	-47.41	-231.84	-519.92	-114.66
Dividend Per Share, 1 Yr. Growth %	-	4.59	-48.64	0.93	-94.62
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	32.52	29.41	28.94	-11.91	-16.41
Gross Profit, 2 Yr. CAGR %	34.34	28.89	28.45	-17.96	-27.03
EBITDA, 2 Yr. CAGR %	30.5	18.74	28.04	-9.52	-56.07
EBITA, 2 Yr. CAGR %	30.24	17.29	28.91	-14.22	-71.07
EBIT, 2 Yr. CAGR %	30.85	17.06	28.87	-15.03	-81.17
Earnings From Cont. Operations, 2 Yr. CAGR %	38.32	41.07	31.03	-23.69	-75.61
Net Income, 2 Yr. CAGR %	38.13	38.03	26.87	-28.39	-75.48
Normalized Net Income, 2 Yr. CAGR %	40.77	23.8	13.68	-25.74	-69.68
Diluted EPS Before Extra, 2 Yr. CAGR %	25.5	19.24	21.11	-29.03	-74.51
Accounts Receivable, 2 Yr. CAGR %	38.39	22.37	18.18	-50.68	-48.46
Inventory, 2 Yr. CAGR %	46.91	33.48	29	20.59	25.97
Net Property, Plant and Equip., 2 Yr. CAGR %	44.08	34.99	48.85	15.87	0.17
Total Assets, 2 Yr. CAGR %	107.35	90.3	14.53	6.41	2.6
Tangible Book Value, 2 Yr. CAGR %	117.9	79.56	-0.9	6.43	-0.21
Common Equity, 2 Yr. CAGR %	112.3	96.23	9.5	6.61	1.94
Cash From Operations, 2 Yr. CAGR %	97.93	53.23	41.85	35.84	-73.49
Capital Expenditures, 2 Yr. CAGR %	-29.09	7.25	113.03	-46.8	-47.95
Levered Free Cash Flow, 2 Yr. CAGR %	7.89	-32.35	-16.64	135.49	-20.77
Unlevered Free Cash Flow, 2 Yr. CAGR %	7.89	-32.27	-16.73	135.29	-21.54
Dividend Per Share, 2 Yr. CAGR %	-	-	-26.68	-28	-76.69
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	40.77	38.71	22.36	5.65	-8.56
Gross Profit, 3 Yr. CAGR %	49.09	39.77	21.91	0.61	-16.57
EBITDA, 3 Yr. CAGR %	125	32.12	19.76	3.28	-38.15
EBITA, 3 Yr. CAGR %	168.32	32.12	19.18	-0.21	-53.02
EBIT, 3 Yr. CAGR %	178.18	32.17	19.05	-0.89	-64.79
Earnings From Cont. Operations, 3 Yr. CAGR %	193.51	46.58	27.56	-1.4	-60.41
Net Income, 3 Yr. CAGR %	183.52	44.21	24.95	-6.93	-60.52
Normalized Net Income, 3 Yr. CAGR %	152.54	35.06	16.78	-11.82	-54.28
Diluted EPS Before Extra, 3 Yr. CAGR %	150.81	31.52	13.02	-9.96	-59.52
Accounts Receivable, 3 Yr. CAGR %	60.61	34.92	17.7	-32.17	-33.87
Inventory, 3 Yr. CAGR %	27.53	41.17	31.51	23.76	26.54
Net Property, Plant and Equip., 3 Yr. CAGR %	71.93	50.56	34.92	30.2	10.58
Total Assets, 3 Yr. CAGR %	70.71	72.57	58.39	10.62	4.92
Tangible Book Value, 3 Yr. CAGR %	78.42	61.41	52.91	0.1	3.36
Common Equity, 3 Yr. CAGR %	74.44	70.45	61.37	7.69	4.28
Cash From Operations, 3 Yr. CAGR %	53.25	94.2	36.21	51.1	-57.71
Capital Expenditures, 3 Yr. CAGR %	-5.96	14.82	20.14	-5.21	-25.81
Levered Free Cash Flow, 3 Yr. CAGR %	-	-15.16	-15.37	42.76	-5.97
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-15.09	-15.43	42.79	-6.72
Dividend Per Share, 3 Yr. CAGR %	35.46	-	-	-18.44	-69.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	35.91	15.67	5.06
Gross Profit, 5 Yr. CAGR %	-	-	40.46	12.94	-0.71
EBITDA, 5 Yr. CAGR %	-	-	79.8	13.55	-19.71
EBITA, 5 Yr. CAGR %	-	-	100.4	11.16	-32.26
EBIT, 5 Yr. CAGR %	-	-	104.49	10.76	-43.07
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	112.58	12.89	-34.18
Net Income, 5 Yr. CAGR %	-	-	105.54	8.99	-34.86
Normalized Net Income, 5 Yr. CAGR %	-	-	83.51	6.33	-31.9
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	87.45	2.83	-37.6
Accounts Receivable, 5 Yr. CAGR %	-	-	42.06	-9.78	-15.41
Inventory, 5 Yr. CAGR %	-	-	28.11	32.55	29.27
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	62.3	35.58	19.77
Total Assets, 5 Yr. CAGR %	-	-	45.52	42.23	33.13
Tangible Book Value, 5 Yr. CAGR %	-	-	41.02	36.64	28.91
Common Equity, 5 Yr. CAGR %	-	-	44.79	41.28	34.29
Cash From Operations, 5 Yr. CAGR %	-	-	48.58	68.33	-29.22
Capital Expenditures, 5 Yr. CAGR %	-	-	30.42	-15.6	-14.02
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	27.63	-17.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	27.65	-17.93
Dividend Per Share, 5 Yr. CAGR %	-	-	5.97	-	-